Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled, crossover design trial tested the
effect of lacosamide on alcohol self-administration and craving following a priming dose of
alcohol. The specific objective of this study was to determine whether lacosamide, a novel
anticonvulsant that is FDA-approved for treating partial seizures, has effects on alcohol
craving and consumption.
Phase:
Phase 1
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)